Moderna joins ABPI; aims to strengthen its footprint in UK


Share post:

Moderna has joined one of the UK’s leading pharmaceutical industry body, Association of the British Pharmaceutical Industry (ABPI) to expand its footprint and investment in the UK.

The biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines will strengthen its footprint with the new state-of-the-art vaccine research, development and manufacturing facility in the UK. It will create valuable new jobs and build on the strength of the UK’s life sciences ecosystem.

The company is best known for their work during the COVID-19 pandemic and are now developing a range of mRNA-based vaccines for a number of conditions.

The ABPI represents companies of all sizes who invest in discovering the medicines of the future, including some of the world’s largest, most innovative, and most successful pharmaceutical firms.

Darius Hughes, UK General Manager, Moderna, said: “We are delighted to join the ABPI – this alliance is an important part of our long-term commitment to the UK and supports the wider significant investments in manufacturing, research and development we are making in this country.

“Moderna is committed to delivering the greatest possible impact to people through mRNA medicines. We look forward to working with the ABPI and our fellow member companies to build on the already strong UK environment for science and innovation.”

Richard Torbett, Chief Executive, ABPI, said: “I’m delighted to welcome Moderna into membership as a world-leading pharmaceutical company that can help bring the UK closer to realising its ambitions to be a leading global centre for life sciences.

“With Moderna’s help we will be in an even stronger position to make the UK the best place in the world to research, develop and use new medicines and vaccines.”


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

FIP policy statement emphasises pharmacy’s vital role in life-course vaccination

The International Pharmaceutical Federation (FIP) has issued a new policy statement which encourages a “life-course” approach to vaccination...

Shadow Health Minister Preet Kaur Gill visits pharmacy in Staffordshire

Preet Kaur Gill, Shadow Minister for Primary Care and Public Health, has paid a recent visit to a...

Superdrug to halt single-use vape sales in UK, Ireland due to environmental concerns

British pharmacy chain Superdrug has announced plans to cease the sale of disposable vapes in all its UK...

Closure of temporary registers by 31 March 2024: GPhC

Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the...